What does CUSIP 738920107 represent in this 13F holders report?

CUSIP 738920107 is the security identifier for ASBP - Aspire Biopharma Holdings, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held ASBP - Aspire Biopharma Holdings, Inc. - Common Stock in Q1 2025?

15 institutional investors reported ASBP - Aspire Biopharma Holdings, Inc. - Common Stock for Q1 2025. Use the holders table for investor-level position and value details.

Aspire Biopharma Holdings, Inc. - Common Stock (ASBP)

CUSIP: 738920107

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class: Equity / Common Stock
Shares outstanding: 138,530,928
Total 13F shares: 1,435,984
Share change: +1,435,984
Total reported value: $875,750
Price per share: $0.58
Number of holders: 15
Value change: +$875,750
Number of buys: 15

Quarterly Holders Quick Answers

What is CUSIP 738920107?
CUSIP 738920107 identifies ASBP - Aspire Biopharma Holdings, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2025

Recent filing periods for CUSIP 738920107:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025

Top shareholders of ASBP - Aspire Biopharma Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Harraden Circle Investments, LLC	13D/G	—	0.31%	150,000	$70,500	$0	31 Mar 2025	13D/G
Surendra K. Ajjarapu	3/4/5	Chief Executive Officer, Director, 10%+ Owner	— class O/S missing	4,317,500	—	—	18 Aug 2023	3/4/5
PowerUp Sponsor LLC	3/4/5	10%+ Owner	— class O/S missing	2,870,000	—	—	18 Aug 2023	3/4/5

Institutional Holders of Aspire Biopharma Holdings, Inc. - Common Stock (ASBP) as of Q1 2025

As of 31 Mar 2025, Aspire Biopharma Holdings, Inc. - Common Stock (ASBP) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,435,984 shares. The largest 10 holders included TORONTO DOMINION BANK, Crewe Advisors LLC, Harraden Circle Investments, LLC, Optivise Advisory Services LLC, Procyon Advisors, LLC, Periscope Capital Inc., Platform Technology Partners, UBS Group AG, TWO SIGMA SECURITIES, LLC, and CITADEL ADVISORS LLC. This page lists 15 institutional shareholders reporting positions in this security for the Q1 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2025 vs Q4 2025 Across Filers

Q4 2025 holders

Q1 2025 holders

Holder diff

-15

Investor	Q4 2025 Shares	Q1 2025 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q1 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.